Enzymatic Analysis of Tet Proteins: Key Enzymes in the Metabolism of DNA Methylation by Shen, Li & Zhang, Yi
Enzymatic Analysis of Tet Proteins: Key Enzymes in the
Metabolism of DNA Methylation
Li Shen*,† and Yi Zhang*,†,1
*Howard Hughes Medical Institute
†Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center,
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Abstract
One of the most exciting recent advances in the epigenetic field is the discovery that 5-
methylcytosine (5mC) in DNA can be iteratively oxidized by a family of proteins known as Tet
proteins to generate 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-
carboxylcytosine (5caC). These 5mC derivatives can be further processed by thymine-DNA
glycosylase (TDG) followed by base excision repair or by replication-dependent dilution leading
to DNA demethylation. Given the similarity between 5mC and its oxidation derivatives, many of
the conventional techniques used for 5mC analysis cannot distinguish between 5mC and 5hmC/
5fC/5caC. Here, we describe 2D-TLC and mass spectrometry methods that we have successfully
used in differentiating 5mC from its oxidative derivatives as well as in characterizing the
enzymatic activity of Tet proteins both in vitro and in vivo.
1. INTRODUCTION
One of the recent advances in the epigenetic filed is the discovery that Tet family proteins
are capable of catalyzing the oxidation of 5-methylcytosine (5mC), a well-characterized
epigenetic mark, into 5-hydroxymethylcytosine (5hmC) in mammalian DNA (Ito et al.,
2010; Tahiliani et al., 2009). Remarkably, more recent studies have shown that 5hmC can be
further oxidized by Tet proteins to generate 5-formylcytosine (5fC) and 5-carboxylcytosine
(5caC) (He et al., 2011; Ito et al., 2011), which have also been detected in the mouse
genome (Ito et al., 2011; Pfaffeneder et al., 2011). These new findings suggest that Tet
protein-catalyzed iterative oxidation of 5mC could be the initial steps in DNA demethylation
pathways (Fig. 5.1). Indeed, immunostaining of the zygotic DNA have shown that loss of
5mC in the male pronucleus correlates with the appearance of 5hmC, 5fC, and 5caC (Gu et
al., 2011; Inoue, Shen, Dai, He, & Zhang, 2011; Inoue & Zhang, 2011; Iqbal, Jin, Pfeifer, &
Szabo, 2011; Wossidlo et al., 2011), which are gradually diluted in a replication-dependent
manner during mouse preimplantation development (Inoue et al., 2011; Inoue & Zhang,
2011). In addition to this passive demethylation process, both 5fC and 5caC, but not 5mC
and 5hmC, can be actively removed from the genome by thymine-DNA glycosylase (TDG)
through a base excision repair pathway (He et al., 2011; Maiti & Drohat, 2011). Thus, Tet-
mediated iterative oxidation of 5mC plays an important role in regulating DNA methylation
dynamics.
However, conventional approaches for DNA methylation studies, including bisulfite
genomic sequencing and methylation-sensitive restriction enzyme digestion, cannot
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discriminate 5mC from other 5mC oxidation products such as 5hmC (Huang et al., 2010;
Jin, Kadam, & Pfeifer, 2010). It was also reported that 5fC and 5caC are interpreted as
unmodified C in bisulfite genomic sequencing (Booth et al., 2012; He et al., 2011). To
overcome these technical difficulties and to study Tet-mediated iterative oxidation, several
techniques have been developed which allow quantification and genome-wide mapping of
the cytosine derivatives. These techniques include (1) thin-layer chromatography (TLC)
analysis of modified nucleotides (Ito et al., 2010; Kriaucionis & Heintz, 2009; Tahiliani et
al., 2009), (2) liquid chromatography and mass spectrometry (LC-MS) analysis (Globisch et
al., 2010; Ito et al., 2011; Munzel et al., 2010), (3) cytosine modification-specific antibodies
(Ficz et al., 2011; Williams et al., 2011; Wu et al., 2011), (4) glucosylation of 5hmC
(Kinney et al., 2011; Szwagierczak, Bultmann, Schmidt, Spada, & Leonhardt, 2010), (5)
chemical/enzymatic labeling or conversion of modified cytosine (Booth et al., 2012; Pastor
et al., 2011; Song, Szulwach, et al., 2011; Yu et al., 2012), and (6) single-molecule, real-
time sequencing (Flusberg et al., 2010; Song, Clark, et al., 2011).
Here, we describe two methods that we have been using in studying the Tet enzymatic
activity. The 2D-TLC method is easy to follow and does not require additional instruments,
while the mass spectrometry method is more accurate and sensitive and can be used to
quantify the levels of cytosine derivatives in genomic DNA.
2. EXPRESSION AND PURIFICATION OF TET PROTEINS
For production of recombinant proteins, cDNAs encoding the catalytic domains of mouse
Tet1 (aa1367–2039), Tet2 (aa916–1921), Tet3 (aa697–1668), and their corresponding
catalytic mutants (Ito et al., 2010) are cloned into a modified pFastBac-HTb (Invitrogen)
insect cell expression vector inframe with a FLAG tag at the N-terminus. Constructs are
transformed into DH10Bac Escherichia coli (Invitrogen) following manufacturer’s
instructions to generate bacmid DNA. Since recombinant bacmid DNA is ≥ 135 kbp, most
silica-gel-membrane-based plasmid miniprep kits are not suitable for bacmid DNA isolation,
anion-exchange-resin-based kits should be used instead (e.g., PureLink HiPure Plasmid
Miniprep Kit (Invitrogen)). Alternatively, we found that crude purification of bacmid DNA
using conventional alkaline lysis followed by ethanol precipitation could also give satisfying
results in the subsequent Sf9 cell transfections. To verify the successful transposition of Tet
cDNAs to bacmid DNA, polymerase chain reaction (PCR) analysis is performed with pUC/
M13 forward (5′-CCCAGTCACGACGTTGTAAAACG-3′) and reverse (5′-
AGCGGATAACAATTTCACACAGG-3′) primers. A PCR band of ~2400 bp+ the size of
the insert indicates successful transposition, otherwise, an ~350 bp band will show up. Once
correct bacmid DNA is generated, baculovirus can be produced in Sf9 cells.
Sf9 cells are maintained at a density of 0.5–6×106 cells/ml in Sf-900 II SFM medium
(Invitrogen) containing 10% fetal bovine serum in a spinner flask at 27 °C. Before
transfection, cells are seeded in a six-well plate with 9×105 cells/well and allowed to attach
for 1 h at 27 °C. Dilute 1 μg of bacmid DNA (or the amount from 100 μl of bacteria if crude
bacmid DNA is used) and 8 μl of Cellfectin II (Invitrogen) separately with 100 μl of
Grace’s Insect Medium (unsupplemented). Combine the diluted bacmid with diluted
Cellfectin II reagent and incubate at room temperature for 30 min. While the transfection
complexes are forming, remove the medium from the plate and wash cells once with 2 ml of
Grace’s Insect Medium (unsupplemented). Remove the wash medium, add 800 μl of
Grace’s Insect Medium (unsupplemented) to the transfection mixture and gently add the
mixture onto the cells immediately. Incubate cells for 5 h at 27 °C before replacing the
transfection mixture with 2 ml of complete growth medium (Sf-900 II SFM medium
containing 10% fetal bovine serum). After 96 h, collect the medium and centrifuge at 500×g
for 5 min to remove floating cells. Transfer the supernatant containing baculovirus to a new
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tube and store the P1 viral stock at 4 °C protected from light. To verify the successful
production of virus, expression of recombinant Tet proteins in the transfected cells can be
examined by Western blot, although the expression may be weak at this stage. To amplify
the P1 viral stock, seed 2×106 cells/well in a six-well plate, add 50 μl of P1 viral stock, and
incubate for 72 h. Collect the P2 viral stock as per the P1 stock. We usually further amplify
the P2 viral stock to generate P3 viral stock of higher titer. Seed 9×106 cells/dish in a 10 cm
dish, add 250 μl of P2 viral stock, and incubate for 72 h. The titer of the P3 viral stock is
usually ~2×108 pfu/ml.
To express the Tet proteins, prepare 1 l of Sf9 cells in mid log growth phase (1.5–2×106
cells/ml) in a spinner flask, infect the cells with 20 ml P3 viral stock (the multiplicity of
infection (MOI) is ~2) for 72 h. Cells are collected and washed once with ice-cold phosphate
buffered saline. Cell pellet is then resuspended in 40 ml of LysisBuffer F (50 mM HEPES,
500 mM NaCl,2 mM MgCl2, 2 mM DTT, 0.2% NP-40, 20% glycerol, 1× protease inhibitors
without EDTA (Roche), pH 8.0) and transferred to a Dounce homogenizer with a type A
pestle. Homogenize slowly for 30 times over a 30-min period on ice and centrifuge the cell
lysate at 14,000 ×g for 20 min at 4 °C. While centrifuging the cell lysate, wash 1 ml of 50%
slurry of FLAG M2 beads (Sigma) with 20 ml Lysis Buffer F in a 50 ml conical tube, spin at
500×g for 5 min, remove the supernatant. Transfer the supernatant of the cell lysate to the
tube and rotate at 4 °C for 3 h. After the incubation, collect beads by spinning at 500×g for 5
min at 4 °C, wash beads with 30 ml Wash Buffer (50 mM HEPES, 150 mM NaCl, 2 mM
MgCl2, 1 mM DTT, 20% glycerol) for three times, and elute the protein with 500 μl Wash
Buffer containing 200 μg/ml 3×FLAG peptide (Sigma) by rotating at 4 °C for 30 min.
Aliquot the eluted protein and store at −80 °C. The purity of the eluted protein can be
determined by Coomassie staining of an SDS-PAGE.
3. TET ACTIVITY ASSAYS
3.1. Preparation of the substrates
To set up the in vitro enzymatic assays, proper DNA substrates are required. If the reaction
products are to be analyzed by TLC assay, the modified cytosine should be placed in the
context of a restriction site that can be digested regardless of the modification. Since TaqI
(with a recognition site of TCGA) is insensitive to all cytosine modifications (Ito et al.,
2011), we have been using double-stranded 20-mer DNA containing a TaqI site as our
substrate with the following sequences:
Taq20-F: 5′-GTTCAGCTTXGATCACGCTC-3′
Taq20-R: 5′-GAGCGTGATXGAAGCTGAAC-3′
(X represents a modified cytosine)
However, if mass spectrometry is to be used as the detection method, the modified cytosine
can be placed anywhere in the strand. Besides the above 20-mer DNA, we have also been
using a double-stranded 38-mer DNA containing nine modified cytosines in each strand as
in natural situation where the modified cytosines might be clustered together:
38mer-F: 5′-AGCCXGXGCXGXGCXGGTXGAGXGGCXGCT CCXGCAGC-3′
38mer-R: 5′-GCTGCXGGAGCXGCCXCTCXACCXGCXCXGC XCXGGCT-3′
Oligonucleotides containing 5mC and 5hmC can be directly purchased from Integrated
DNA Technologies, while those containing 5fC and 5caC are synthesized as described (Dai
& He, 2011). However, the phosphoramidite forms of both 5fC and 5caC have become
commercially available recently from Glen Research. Therefore, oligonucleotides containing
5fC and 5caC can now be synthesized in most oligonucleotide synthesis facilities.
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After synthesis of the oligonucleotides containing the desired modification, the
oligonucleotides are annealed in 1×NEB Buffer 2 by boiling the mixture for 5 min and
slowly cooling down to room temperature. High-quality double-stranded DNA can be
further purified by polyacrylamide gel electrophoresis if necessary.
3.2. In vitro enzymatic assays
For in vitro enzymatic activity assays, 0.5 μg of various double-stranded DNA substrates are
incubated with 1.2 μg of wild-type or catalytic mutant Tet proteins (~1:6 enzyme/substrate
ratio if the 20-mer substrate is used; 50 μl reaction) in the presence of 50 mM HEPES (pH
7.9), 100 mM NaCl, 75 μM Fe(NH4)2(SO4)2, 2 mM ascorbate, 1 mM α-ketoglutarate (2-
oxoglutarate), 1 mM DTT and 1 mM ATP at 37 °C for 40 min. Since Tet proteins are
quickly inactivated under the reaction condition, it is necessary to shorten the incubation
time to 2.5 min if kinetic studies are to be performed (Ito et al., 2011). The reactions are
stopped by the addition of 10 volumes of ice-cold Buffer PN (QIAGEN), and the
oligonucleotides are then purified using QIAquick Nucleotide Removal Kit (QIAGEN)
following manufacturer’s instructions. Now, the oligonucleotides are ready to be analyzed
by either 2D-TLC or mass spectrometry.
3.3. In vivo enzymatic assays in HEK293T cells
HEK293T cells contain low levels of endogenous 5hmC, 5fC, and 5caC. Since high
transfection efficiency (>90%) and high Tet protein expression can be achieved in
HEK293T cells, it provides an ideal system for analyzing enzymatic activity of Tet proteins
in vivo. To overexpress Tet proteins in HEK293T cells, cDNAs encoding the full-length or
catalytic domains of mouse Tet proteins and their corresponding catalytic mutants are
cloned into a modified pcDNA3 (Invitrogen) mammalian cell expression vector in-frame
with a FLAG tag at the N-terminus. 8×105 cells/well are seeded into a six-well plate on the
day before transfection. The cells are transfected with 2 μg of Tet expression constructs with
FuGENE HD (Roche; 1:3 plasmid/FuGENE HD ratio) following manufacturer’s
instructions. 48 h after transfection, the transfected cells are harvested and genomic DNA is
extracted using a DNeasy Blood & Tissue Kit (QIAGEN; include the optional RNase A
treatment step during genomic DNA extraction and elute with Buffer EB). The genomic
DNA is now ready to be analyzed by either 2D-TLC or mass spectrometry.
4. ANALYSIS OF THE CYTOSINE DERIVATIVES BY 2D-TLC
TLC is a classic method that separates different nucleotides based on their differential
migration rates on TLC plates. TLC assays have been used successfully for analyzing 5hmC
in previous studies (Koh et al., 2011; Kriaucionis & Heintz, 2009; Tahiliani et al., 2009).
However, under previous TLC conditions, 5hmC and 5fC have almost identical migration
patterns, and 5caC fails to migrate (Ito et al., 2011). To overcome this technical problem, we
developed a modified 2D-TLC assay using a more acidic buffer as the second developing
condition. For 2D-TLC analysis, the in vitro enzymatic reaction products (or 10 μg of
genomic DNA) are digested with 40 U of TaqI (use 100 U for genomic DNA) overnight,
and then 20 U of calf intestinal alkaline phosphatase (CIAP) are added, followed by two
more hours of incubation. The digested DNA is purified with QIAquick Nucleotide
Removal kit. The DNA is then endlabeled with 40 U of T4 polynucleotide kinase and 15
μCi of [γ-32P]-ATP (25 Ci/mmol) for 1 h, ethanol-precipitated, and redissolved in 40 μl of
water. Then, the labeled DNA is heat-denatured and digested into nucleotides with 200 U of
nuclease S1 (Sigma) in the presence of 0.5 mM ZnSO4, 14 mM sodium acetate (pH 5.2) at
37 °C for 2 h (total volume is 50 μl) before being analyzed by 2D-TLC.
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For 2D-TLC assay, 1.5 μl of the digestion product is spotted on one corner of a 20×20 cm
Polyethyleneimine cellulose F TLC plate (Merck), and the TLC plate is developed using
TLC Buffer 1 (isobutyric acid: NH4OH: H2O=66:2:20). After complete drying, the TLC
plate is developed in the second direction using TLC Buffer 2 (isopropanol: HCl: H2O
70:15:15). After drying, the TLC plate is exposed to an X-ray film for autoradiography or a
storage phosphor screen for better quantitation. A representative 2D-TLC assay result is
shown in Fig. 5.2. To confirm the migration patterns of the cytosine derivatives, standard
nucleosides (Berry & Associates) can be labeled with deoxycytidine kinase
(Proteinkinase.de) in the presence of [γ-32P]-ATP and analyzed in parallel with the samples
using the same 2D-TLC procedure.
5. ANALYSIS OF THE CYTOSINE DERIVATIVES BY MASS SPECTROMETRY
For quantitative analysis of the cytosine derivatives, we developed a sensitive and specific
method using liquid chromatography-tandem mass spectrometry (LC-MS/MS) with multiple
reactions monitoring (MRM) to simultaneously detect and quantitate cytosine derivatives
(Ito et al., 2011). The instrument we have been using is an ultra-performance liquid
chromatography system (Waters) coupled to a TSQ-Quantum Ultra triple-quadrupole mass
analyzer (ThermoFinnigan) with a heat-assisted electrospray ionization source, which can
detect and quantitate as low as 10 fmol of cytosine derivatives (Fig. 5.3A).
To prepare the samples, in vitro enzymatic reaction products or 2.5 μg of genomic DNA are
heat-denatured, hydrolyzed with 90 U of nuclease S1 in Buffer 1 (0.5 mM ZnSO4, 14 mM
sodium acetate, pH 5.2) at 37 °C for at least 1 h (total volume is 44.5 μl), followed by the
addition of 5 μl 10×Buffer 2 (560 mM Tris–HCl, 30 mM NaCl, 10 mM MgCl2, pH 8.3), 0.5
μg of phosphodiesterase I and 2 U of CIAP for an additional 1 h (final volume is 50 μl).
Then, the digested DNA is filtered with Nanosep3K to remove enzymes and undigested
DNA (if any). For the in vitro enzymatic reaction products, dilute the samples to 200 μl, and
subject 10 μl of the diluted samples to LC-MS/MS analysis. For genomic DNA, directly
subject 10 μl of the filtered samples to LC-MS/MS analysis.
Separation prior to mass spectrometry is achieved using a 2.1×100 mm HSS T3 1.8 μm
column (Waters) with gradient elution at a flow rate of 0.2 ml/min using 0.02% acetic acid
in water as mobile phase A and methanol as mobile phase B. The gradient is 0→3.5 min,
3% B, 3.5→12.5 min, 3%→16.2% B, 12.5→13 min, 16.2%→30% B, 13→15 min, 30% B,
15→16 min, 30%→3% B, 16→20 min, 3% B. The mass spectrometer is set to positive
mode, precursor to product ion transitions for cytosine and its derivatives are monitored
using the parameters in Tables 5.1 and 5.2. External standard calibration is used for the
quantitation. To correct for matrix effects, the calibration curves for nucleoside standards
(Berry & Associates) are generated by mixing the nucleosides with the enzymes in the
digestion buffer and then filtered using the same procedures used for the samples.
Calibration curves are constructed for each batch of analysis. It is also important to include
one standard sample every 10 samples to check the signal stability of the instrument.
6. ANALYSIS OF THE ENDOGENOUS LEVEL OF CYTOSINE DERIVATIVES
BY MASS SPECTROMETRY
For endogenous 5fC and 5caC in genomic DNA, they are first enriched by HPLC
fractionation before being analyzed by mass spectrometry (Fig. 5.3B and C) (Ito et al.,
2011). Before analyzing genomic DNA, the retention time for each of the cytosine
derivatives needs to be determined using standard nucleosides (Fig. 5.3C). We have noticed
that the retention time of 5caC is sensitive to pH of the digestion buffer and the mobile
phase, thus the standard nucleosides should be prepared in the sample digestion buffer
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before HPLC analysis, and the pH of mobile phase A should also be accurately adjusted. To
avoid carry-over of the standard nucleosides, it is necessary to make several blank injections
before sample analysis. We also include the fractions from the last blank injection in the
subsequent LC-MS/MS analysis to make sure there is no carry-over.
To enrich 5fC and 5caC, 20–100 μg of genomic DNA is heat-denatured, hydrolyzed with
nuclease S1 (20 U/μg of DNA) in Buffer 1 (0.5 mM ZnSO4, 14 mM sodium acetate, pH 5.2)
at 37 °C for at least 1 h (total volume is 250 μl), followed by the addition of 30 μl 10×
Buffer 2 (560 mM Tris–HCl, 30 mM NaCl, 10 mM MgCl2, pH 8.3), 5 μg of
phosphodiesterase I and 20 U of CIAP for an additional 1 h (final volume is 300 μl), and
filtered with Nanosep3K to remove enzymes and undigested DNA (if any). Then, 275 μl of
the filtered samples are subjected to HPLC (Agilent 1200 with a 4.6×150 mm, 3 μm,
Atlantis T3 column) with gradient elution at a flow rate of 0.8 ml/min using 5 mM
ammonium formate in water (pH 4.0) as mobile phase A and methanol as mobile phase B.
The gradient is 0→15 min, 3%→30% B, 15→17 min, 30% B, 17→18 min, 30%→3% B,
18→25 min, 3% B. During the HPLC separation, fractions corresponding to the retention
time of 5hmC, 5fC, and 5caC are collected for LC-MS/MS quantitation, while C and 5mC
are directly quantitated with external standard curves using the UV detector signals (Fig.
5.3C). The collected fractions are then dried with a Speed-Vac and redissolved with 20 μl of
water. Of which, 15 μl is subjected to LC-MS/MS analysis as described above. External
standard calibration is used for the quantitation. We suggest make new calibration curve for
each batch of analysis and include one standard for every 10 samples to confirm the signal
stability of the instrument.
Considering the sample loss during sample enrichment, the recovery rates of 5hmC, 5fC,
and 5caC need to be determined and used to correct the percentages of the cytosine
derivatives in total cytosines. To determine the recovery rates, standard 5hmC, 5fC, and
5caC nucleosides are mixed at five different levels with 15 nmol (if 20 μg of genomic DNA
is analyzed) each of C, G, T, A in the digestion buffer, then the standard mixtures are
analyzed by the same procedures as that used for genomic DNA samples. Finally, measured
percentages (cytosine derivative/total cytosine) in the standard mixtures are plotted against
the actual percentages. The recovery rates determined are usually ~50% for all the cytosine
derivatives and can be used to correct the measured results for genomic DNA samples.
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Proposed models of Tet-initiated DNA demethylation pathways. DNA methylation (5mC) is
established and maintained by DNA methyltransferases (Dnmt). In mammals, 5mC can be
oxidized by the Tet proteins to generate 5hmC, 5fC, and 5caC. These 5mC derivatives,
specifically 5fC and 5caC, can be actively removed through base excision repair initiated by
the glycosylase TDG or can be passively removed through replication-dependent dilution
during preimplantation development. 5hmC may also be deaminated by AID/APOBEC into
5hmU, which can be removed by TDG or SMUG1. In addition, a putative decarboxylase
may directly convert 5caC to C.
Shen and Zhang Page 9














A representative autoradiograph of 2D-TLC analysis of the enzymatic reaction product
derived from 5mC-containing 20-mer oligo DNA incubated with Tet2 protein.
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Analysis of the cytosine derivatives using mass spectrometry. (A) Representative LC-MS/
MS chromatograms at the limits of detection for 5hmC (2.5 fmol), 5fC (5 fmol), and 5caC
(10 fmol), showing excellent signal-to-noise ratio. (B) Schematic representation of the
procedures used to quantify endogenous cytosine derivatives in genomic DNA. (C) HPLC
analysis of nucleoside standards (top panel) and hydrolyzed genomic DNA. The fractions
corresponding to the retention time of 5hmC/5caC (fraction A) and 5fC (fraction B) are
collected for further LC-MS/MS analysis.
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Table 5.1
MRM transition parameters for monitoring cytosine and its derivatives



















Shen and Zhang Page 13
Table 5.2
Electrospray parameters for the mass spectrometer
ESI mode Positive
Spray voltage 3000 V
Vaporizer temperature 250 °C
Capillary temperature 285 °C
Sheath gas flow rate 35 arb
AUX gas flow rate 25 arb
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